CL063 MHC Class I Qa.m8 antibody

See related secondary antibodies

Search for all "MHC Class I Qa.m8"

0.5 ml / €500.00
Please visit the country specific website of Acris Antibodies or contact your local Distributor to buy this product.

Quick Overview

Mouse anti Mouse MHC Class I Qa.m8 5035-24.1

CL063

More Views

  • CL063
  • CL063
  • CL063
  • CL063

Product Description for MHC Class I Qa.m8

Mouse anti Mouse MHC Class I Qa.m8 5035-24.1.
Presentation: Ascites
Product is tested for Cytotoxicity Assay.

Properties for MHC Class I Qa.m8

Product Category Primary Antibodies
Quantity 0.5 ml
Presentation Ascites
Reactivity Ms
Applications CT
Clonality Monoclonal
Clone 5035-24.1
Host Mouse
Isotype IgG3
Shipping to Worldwide
PDF datasheet View Datasheet
Manufacturer Acris Antibodies GmbH
Material safety datasheet MSDS for Monoclonal Antibodies (de)

Datasheet Extract

Immunogen
Swiss Prot Num:
P14430
Immunogen:
Recipient: BALB/c
Donor: B6.Ly1a
Fusion Partner: P3-NSI/1-Ag4(NS-1)
Add. information The reagent is not sold as sterile, but can be sterilized by filtration if necessary. To minimize loss of volume during filtration, dilute to the final working concentration in the appropriate medium before filtration and filter through a 0.45 µ millipore filter (or equivalent).
Application Cytotoxicity Assay.
Flow Cytometry.
Background The Qa region, so named because of the closely linked Qa 1-9 loci, is situated on murine chromosome 17 between the H-2D and T1a loci. These Qa loci code for cell surface alloantigens expressed on some lymphoid and myeloid cells. Their expression appears to be controlled by a gene or genes closely linked to the H-2D locus and they have been identified as being structurally related to the murine H-2 antigens. Although no functional role for Qa antigens has been determined, the restricted and differential distribution of Qa determinants on hemopoietic and lymphoid cells raises the possibility that they may not be simply differentiation markers but may play a role in hematopoetic differentiation.
Protocols RECOMMENDED METHOD FOR DEPLETING A CELL POPULATION OF Qa.m8 POSITIVE LYMPHOCYTES
1. Prepare a cell suspension from the appropriate tissue in Cytotoxicity Medium or equivalent. Remove red cells and dead cells (where necessary) by purification of viable lymphocytes on Lympholyte®-M density cell separation medium. After washing adjust the cell concentration to 1 x 10e7 cells per ml in Cytotoxicity Medium.
2. Add the antibody to a final concentration 1/20 and mix. Alternately, pellet the cells and resuspend in antibody diluted 1/20 in Cytotoxicity Medium.
3. Incubate for 60 minutes at 4°C.
4. Centrifuge to pellet the cells and discard the supernatant.
5. Resuspend to the original volume in Low-Tox®-M Rabbit Complement3, diluted to the appropriate concentration in Cytotoxicity Medium. (Recommended concentration included with each batch of Low-Tox®-M Rabbit Complement.)
6. Incubate for 60 minutes at 37°C.
7. Monitor for percent cytotoxicity at this stage, before further processing. For this purpose, remove a small sample from each tube, dilute 1/10 with medium, and add 1/10 volume of 1% trypan blue. After 3-5 minutes, score live vs. dead cells in a hemacytometer.
8. For functional studies, remove the dead cells from the treated groups before further processing, particularly if the treated cells are to be cultured. This can be done by layering the treated cell suspensions over an equal volume of Lympholyte®-M cell separation medium and centrifuging at room temperature as per the instruction provided. Live cells will form a layer at the interface, while the dead cells pellet. The interface can then be collected and washed in Cytotoxicity Medium before being resuspended in the appropriate medium for further processing. Alternately, the cells can be washed and resuspended in the appropriate medium for further processing immediately after Step#6, provided that the dead cells will not interfere with subsequent assays.

RECOMMENDED METHOD FOR DETERMINING PERCENT OF Qa.m8 POSITIVE CELLS IN A POPULATION
1. Prepare a cell suspension from the appropriate tissue in Cytotoxicity Medium1 or equivalent. Remove red cells and dead cells (where necessary) by purification of viable lymphocytes on Lympholyte®-M density cell separation medium. After washing, adjust the cell concentration to 1 x 10e6 cells per ml in Cytotoxicity Medium.
2. Add the antibody to a final concentration of 1/40 and mix.
3. Incubate for 60 minutes at 4°C.
4. Centrifuge to pellet the cells and discard the supernatant.
5. Resuspend to the original volume in Low-Tox®-M Rabbit Complement3, diluted to the appropriate concentration in Cytotoxicity Medium. (Recommended concentration included with each batch of Low-Tox®-M Complement).
6. Incubate for 60 minutes at 37°C.
7. Place on ice.
8. Add trypan blue. 10% volume of 1% trypan blue (w/v) added 3-5 minutes before scoring works well. Score live vs. dead cells in a hemacytometer. Cytotoxic Index (C.I.) can be calculated as shown in FIGURE 1.

Notes:
1. Cytotoxicity Medium® is RPMI-1640 with 25mM Hepes buffer and 0.3% bovine serum albumin (BSA). BSA is substituted for the conventionally used fetal calf serum (FCS) because we have found that many batches of FCS contain complement dependent cytotoxins to mouse lymphocytes, thus increasing the background killing in the presence of complement. We recommend that cells not be exposed to FCS prior to or during exposure to antibody and complement. Some batches of BSA also contain complement dependent cytotoxins, resulting in the same problem. We screen for batches of BSA giving low background in the presence of complement and use the selected BSA for preparing Cytotoxicity Medium®.
2. Lympholyte®-M cell separation medium is a density separation medium designed specifically for the isolation of viable mouse lymphocytes. This separation medium provides a high and non-selective recovery of viable mouse lymphocytes, removing red cells and dead cells. The density of this medium is 1.087-1.088. Isolation of mouse lymphocytes on cell separation medium of density 1.077 will result in high and selective loss of lymphocytes and should be avoided.
3. Rabbit serum provides the most potent source of complement for use with antibodies to mouse cell surface antigens. However, rabbit serum itself is very toxic to mouse lymphocytes. Low-Tox®-M Rabbit Complement is absorbed to remove toxicity to mouse lymphocytes, while maintaining its high complement activity. When used in conjunction with Cytotoxicity Medium, this reagent provides a highly potent source of complement with minimal background toxicity.

Antibody Titration:
See FIGURE 2.
Cell Source: Lymph Node
Donor: C57BL/6
Cell Concentration: 1.1x10e6 cells/ml
Complement: Low-Tox®-M Rabbit Complement
Complement Concentration: 1/12
Procedure: Two stage cytotoxicity as described in Recommended Method for Determining Percent of Qa.m8 Positive Lymphocytes.

Strain Distribution:
Procedure: As above
Antibody Concentration: 1/40
Strains tested: C57BL/6, BALB/c, C3H/he, CBA, ATH
Cells killed by treatment: C57BL/6
Cells not killed by treatment: BALB/c, C3H/He, CBA, ATH
Tissue Distribution:
Procedure: as above
Antibody Concentration: 1/40
Strain: C57BL/6

Cell Source C.I.
Thymus: 6
Spleen: 32
Lymph Node: 48
Bone Marrow: 22

FLOW CYTOMETRY ANALYSIS OF SPLENIC T CELLS:
See FIGURE 4.
DONOR: C57BL/6
CELL CONCENTRATION: 1 x 10e6 cells per test.
ANTIBODY CONCENTRATION: 1/1000
CELL SOURCE: Splenic T Cells

RECOMMENDED METHOD FOR LABELLING Qa.m8 POSITIVE CELLS
1. Prepare cell suspension in media A. For cell preparations, deplete the red blood cell population with Lympholyte®-M cell separation medium.
Wash 2 times.
Resuspend cells to 1 x 10e6 cells in approximately 50 µl media A in a microcentrifuge tube (ie. 50 µl of cells resuspended to 2x10e7 cells / ml). The contents of one tube represent one test.
2. To each tube add 50 µl of a 1/500 dilution of this Ab (to make a final dilution of 1/1000).
3. Vortex the tubes to ensure thorough mixing of antibody and cells.
4. Incubate the tubes for 30 minutes at 4°C.
5. Wash 2 times at 4°C.
6. Add 100 µl of secondary antibody (Goat anti-mouse IgG (H+L) FITC conjugate) at a 1/75 dilution.
7. Incubate tubes at 4°C for 30-60 minutes.
8. It is recommended that the tubes are protected from light since most fluorochromes are light sensitive.
9. Wash 2 times at 4°C in media B.
10. Resuspend the cell pellet in 50 µl ice cold media B.
11. Transfer to suitable tubes for flow cytometric analysis containing 15 µl of propidium iodide at 0.5 mg/ml in phosphate buffered saline - (this stains dead cells by intercalating in DNA). N.B. Appropriate control samples should always be included in any labelling studies.

Media:
A. Phosphate buffered saline (pH 7.2) + 0.5% normal serum of host species + sodium azide (100 µl of 2M sodium azide in 100 mls).
B. Phosphate buffered saline (pH 7.2) + 0.5% bovine serum albumin + sodium azide (100 µl of 2M sodium azide in 100 mls).
General Readings
  1. Walker ID, Sandrin MS, Hogarth PM, Sutton VR, McKenzie IF. Expression of Qa alloantigens on peripheral T cells: the relationship of the Qa-m2, 7, 8, 9 specificities. Immunogenetics. 1986;24(2):90-4. PubMed PMID: 2427442.
  2. Sandrin, M.S., Hogarth, M. and I.F.C. McKenzie. Two Qa Specificities: Qa.m7 and Qa.m8 Defined by Monoclonal Antibodies. (1983). J. of Immunol. 131: 546-547.
  3. Sutton, V.R., Hogarth P.M. and I.F.C. McKenzie, Description of a New Qa Antigenic Specificity, Qa.m9, Whose Expression is under Complex Genetic Control. (1983). J. of Immunol. 131: 1363-1367.
  4. Hogarth PM, Basten A, Prichard-Briscoe H, Henning MH, Sutton VR, McKenzie IF. The distribution of the Qa-2 alloantigen on functional T lymphocytes. J Immunol. 1985 Sep;135(3):1632-6. PubMed PMID: 3160773.
  5. Harris RA, Hogarth PM, Wadeson LJ, Collins P, McKenzie IF, Penington DG. An antigenic difference between cells forming early and late haematopoietic spleen colonies (CFU-S). Nature. 1984 Feb 16-22;307(5952):638-41. PubMed PMID: 6694753.
  6. Hogarth, P.M., Crewther, P.E. and I.F.C. McKenzie. Description of a Qa-2 like alloantigen (Qa-m2) (1982) Eur. J. Immunol. 12:374.
  7. Sutton, V.R., Hogarth, P.M., and I.F.C. McKenzie. Surface Antigens of Murine Lymphocytes. 1988. In : Marchalonis, J.J. (ed.) The Lymphocyte, Structure and Function (2nd edition) Marcel Dekker Inc. N.Y. vol. 37, pg 223-305.
Storage Prior to and following reconstitution store the antibody at -20°C.
Avoid repeated freezing and thawing.
Shelf life: one year from despatch.
Format
State:
Lyophilized Ascites
Ascites
Reconstitution:
Restore with 0.5 ml distilled water.
Species Reactivity
Species reactivity (tested):
Mouse.
Specificity
Specificity:
This antibody reacts to MHC Class I Qa.m8.
This monoclonal Qa.m8 antibody detects the Qa.m8 antigenic determinant on molecule coded by H-2 linked by mapping within the Qa region. It is possible that this specificity represents a discrete epitope on previously described Loci (Qa-2) rather than a product of new Qa loci, which may code for antigenically distinct molecules. In fact, this Qa.m7 antibody defines a Qa antigen which appears to be molecularly similar or identical to antigen defined by antibodies to other Qa specification (i.e. Qa.m2, Qa.m7, Qa.m9). Biochemical studies have inidcated that Qa.m7 is found on a molecule consisting of a 39,000d heavy chain and a 12,000d light chain wgich is B2 Microglobulin.
Qa.m8 is distinguished from other Qa specificities on the basis of unique strain and Tissue distribution pattern obtained. It has been detected on ~37% of spleen and lymph node cells and ~27% of bone marrow cells.
This antibody, in conjunction with others (i.e. anti-Qa.m7 antibody) could prove useful in defining subsets of functional cells.
As each of these antigens are present on subsets of T cells (Qa.m8), B cells (Qa.m7) and bone marrow cells (Qa.m7 and Qa.m8), it may be of interest to if Qa.m7 and Qa.m8 could be used to define subsets of functional cells.

Accessory Products

  • LinkedIn